Structural and thermodynamic stability of uranyl–deferiprone complexes and the removal efficacy of U(vi) at the cellular level

Chemical and radiological toxicity of uranium compounds

(2016) S. V. Gudkov et al.   RUSSIAN JOURNAL OF GENERAL CHEMISTRY

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes

(2016) George J. Kontoghiorghes et al.   Drug Design Development and Therapy

Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with 89Zr4+: comparison with desferrioxamine-B

(2015) Michelle T. Ma et al.   DALTON TRANSACTIONS

Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: Design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains

(2015) Ying-Jun Zhou et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Inhibition of Fe2+- and Fe3+- induced hydroxyl radical production by the iron-chelating drug deferiprone

(2015) V.A. Timoshnikov et al.   FREE RADICAL BIOLOGY AND MEDICINE

Characterization of the Neuroprotective Potential of Derivatives of the Iron Chelating Drug Deferiprone

(2015) Pamela Maher et al.   NEUROCHEMICAL RESEARCH

Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)

(2014) Melissa A. Deri et al.   JOURNAL OF MEDICINAL CHEMISTRY

A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disorders

(2013) Kimberly M. Lincoln et al.   CHEMICAL COMMUNICATIONS

Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections

(2012) Mark J. Mitton-Fry et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Conjugation to Biocompatible Dendrimers Increases Lanthanide T2 Relaxivity of Hydroxypyridinone Complexes for Magnetic Resonance Imaging

(2012) Piper J. Klemm et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Actinide chelation: biodistribution andin vivocomplex stability of the targeted metal ions

(2012) Birgitta Kullgren et al.   TOXICOLOGY MECHANISMS AND METHODS

Uranyl sequestration: synthesis and structural characterization of uranyl complexes with a tetradentate methylterephthalamide ligand

(2011) Chengbao Ni et al.   CHEMICAL COMMUNICATIONS

Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands

(2011) David J. Berry et al.   CHEMICAL COMMUNICATIONS

1-(2-Hydroxyethoxy)Methyl-2-Methyl-3-Hydroxyl-4-Pyridinone: ATargeted, Bifunctional Chelating Agent for Potential Uranic Detoxification in the Kidney

(2011) Gang Liu et al.   HEMOGLOBIN

In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli

(2010) M. G. P. Page et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

BIOMIMETIC ACTINIDE CHELATORS: AN UPDATE ON THE PRECLINICAL DEVELOPMENT OF THE ORALLY ACTIVE HYDROXYPYRIDONATE DECORPORATION AGENTS 3,4,3-LI(1,2-HOPO) AND 5-LIO(ME-3,2-HOPO)

(2010) Rebecca J. Abergel et al.   HEALTH PHYSICS

A gallium complex with a new tripodal tris-hydroxypyridinone for potential nuclear diagnostic imaging: solution and in vivo studies of 67Ga-labeled species

(2010) Sílvia Chaves et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Gd−Hydroxypyridinone (HOPO)-Based High-Relaxivity Magnetic Resonance Imaging (MRI) Contrast Agents

(2009) Ankona Datta et al.   ACCOUNTS OF CHEMICAL RESEARCH

Designing the Ideal Uranyl Ligand: a Sterically Induced Speciation Change in Complexes with Thiophene-Bridged Bis(3-hydroxy-N-methylpyridin-2-one)(1)

(2009) Géza Szigethy et al.   INORGANIC CHEMISTRY

The Effects of Bicarbonate and its Combination with Chelating Agents Used for the Removal of Depleted Uranium in Rats

(2008) Satoshi Fukuda et al.   HEMOGLOBIN